En studie av izalontamab brengitecan kontra cellegift hos deltakere med tidligere ubehandlet, lokalt avansert, tilbakevendende inoperable eller metastatisk trippel-negativ brystkreft som ikke er kvalifisert for anti-PD (L) 1 medisiner (Izabright-Breast01)
En randomisert, en sømløs fase 2/3 studie av Izalontamab Brengitecan (BMS-986507) kontra behandling av legens valg hos pasienter med tidligere ubehandlet, lokalt avansert, tilbakevendende, eller metastatisk trippel-negativ BRE-kreft (TNBC) eller ER-LOV-LOV-LOV-LOV-LOV-LOW-LOW-LOW-LOW-LO-LOV-LOVE2 Anti-PD1/PD-L1-behandling
The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physician's choice (TPC) (paclitaxel, nab-paclitaxel, carboplatin plus gemcitabine, and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative BC patients who are not candidates for anti-PD(L)1 therapy and endocrine therapies.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Fase 2
- Fase 3
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: First line of the email MUST contain NCT # and Site #.
Studer Kontakt Backup
- Navn: BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
- Telefonnummer: 855-907-3286
- E-post: Clinical.Trials@bms.com
Studiesteder
-
-
-
Buenos Aires, Argentina, 1430
- Har ikke rekruttert ennå
- Local Institution - 0346
-
Ta kontakt med:
- Site 0346
-
Buenos Aires, Argentina, 1122
- Fullført
- Local Institution - 0345
-
Buenos Aires, Argentina, 1426
- Aktiv, ikke rekrutterende
- Local Institution - 0012
-
Buenos Aires, Argentina, 1426
- Aktiv, ikke rekrutterende
- Local Institution - 0317
-
Mendoza, Argentina, 5500
- Fullført
- Local Institution - 0348
-
-
Buenos Aires
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, 1280
- Har ikke rekruttert ennå
- Local Institution - 0011
-
Ta kontakt med:
- Site 0011
-
-
Buenos Aires F.D.
-
ABB, Buenos Aires F.D., Argentina, 1181
- Fullført
- Local Institution - 0214
-
-
Córdoba Province
-
Córdoba, Córdoba Province, Argentina, X5004BAL
- Aktiv, ikke rekrutterende
- Local Institution - 0143
-
Río Cuarto, Córdoba Province, Argentina, X5800ALB
- Aktiv, ikke rekrutterende
- Local Institution - 0137
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentina, 2000
- Aktiv, ikke rekrutterende
- Local Institution - 0142
-
-
-
-
New South Wales
-
Macquarie University, New South Wales, Australia, 2109
- Aktiv, ikke rekrutterende
- Local Institution - 0170
-
-
Queensland
-
Brisbane, Queensland, Australia, 4029
- Aktiv, ikke rekrutterende
- Local Institution - 0035
-
-
Victoria
-
Ballarat Central, Victoria, Australia, 3350
- Aktiv, ikke rekrutterende
- Local Institution - 0197
-
Heidelberg, Victoria, Australia, 3084
- Aktiv, ikke rekrutterende
- Local Institution - 0031
-
Melbourne, Victoria, Australia, 3000
- Aktiv, ikke rekrutterende
- Local Institution - 0274
-
-
Western Australia
-
Subiaco, Western Australia, Australia, 6008
- Fullført
- Local Institution - 0028
-
-
-
-
-
Rio de Janeiro, Brasil, 20230-130
- Aktiv, ikke rekrutterende
- Local Institution - 0153
-
São Paulo, Brasil, 01317-000
- Aktiv, ikke rekrutterende
- Local Institution - 0144
-
São Paulo, Brasil, 01401-002
- Aktiv, ikke rekrutterende
- Local Institution - 0149
-
-
Amazonas
-
Manaus, Amazonas, Brasil, 69020-030
- Tilbaketrukket
- Local Institution - 0187
-
-
Ceará
-
Fortaleza, Ceará, Brasil, 60135-237
- Aktiv, ikke rekrutterende
- Local Institution - 0147
-
-
Espírito Santo
-
Vitória, Espírito Santo, Brasil, 29055450
- Fullført
- Local Institution - 0157
-
-
Federal District
-
Lago Sul, Federal District, Brasil, 71681-603
- Tilbaketrukket
- Local Institution - 1038
-
-
Paraná
-
Curitiba, Paraná, Brasil, 81480-580
- Fullført
- Local Institution - 0159
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasil, 90470-340
- Fullført
- Local Institution - 0199
-
-
São Paulo
-
Barretos, São Paulo, Brasil, 14784400
- Aktiv, ikke rekrutterende
- Local Institution - 0148
-
São José do Rio Preto, São Paulo, Brasil, 15090000
- Aktiv, ikke rekrutterende
- Local Institution - 0164
-
-
-
-
British Columbia
-
Kelowna, British Columbia, Canada, V1Y 5L3
- Rekruttering
- BC Cancer Kelowna
-
Ta kontakt med:
- Susan Ellard, Site 0218
- Telefonnummer: +1250-712-3996
-
Victoria, British Columbia, Canada, V8R 6V5
- Tilbaketrukket
- Local Institution - 0217
-
-
Ontario
-
Ottawa, Ontario, Canada, K1H 8L6
- Rekruttering
- The Ottawa Hospital - General Campus
-
Ta kontakt med:
- Xinni Song, Site 0265
- Telefonnummer: 6137377700ext70208
-
-
Quebec
-
Montreal, Quebec, Canada, H4A 3J1
- Rekruttering
- McGill University Health Centre
-
Ta kontakt med:
- Jamil Asselah, Site 0219
- Telefonnummer: 514934193435721
-
Montreal, Quebec, Canada, H2X 3E4
- Rekruttering
- Centre Hospitalier de l'Université de Montréal
-
Ta kontakt med:
- Danielle Charpentier, Site 0215
- Telefonnummer: 5148908000
-
Saint-Charles-Borromée, Quebec, Canada, J6E 6J2
- Rekruttering
- Centre Intégré de Santé et de Services Sociaux de Lanaudière
-
Ta kontakt med:
- Angélique Brunot, Site 0350
- Telefonnummer: 579-593-1172
-
Sherbrooke, Quebec, Canada, J1H 5N4
- Rekruttering
- Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUS
-
Ta kontakt med:
- Michel Pavic, Site 0216
- Telefonnummer: 819-346-1110x74816
-
-
-
-
Santiago Metropolitan
-
Santiago, Santiago Metropolitan, Chile, 7500921
- Fullført
- Local Institution - 0138
-
Santiago, Santiago Metropolitan, Chile, 7650568
- Aktiv, ikke rekrutterende
- Local Institution - 0021
-
Santiago, Santiago Metropolitan, Chile, 8330032
- Aktiv, ikke rekrutterende
- Local Institution - 0017
-
Santiago, Santiago Metropolitan, Chile, 8420383
- Aktiv, ikke rekrutterende
- Local Institution - 0018
-
-
Valparaiso
-
Viña del Mar, Valparaiso, Chile, 2520598
- Fullført
- Local Institution - 0016
-
-
-
-
-
Medellín, Colombia, 050030
- Har ikke rekruttert ennå
- Local Institution - 0349
-
Ta kontakt med:
- Site 0349
-
-
Antioquia
-
Medellín, Antioquia, Colombia, 50021
- Tilbaketrukket
- Local Institution - 0195
-
Rionegro, Antioquia, Colombia, 054047
- Har ikke rekruttert ennå
- Local Institution - 0201
-
Ta kontakt med:
- Site 0201
-
-
Atlántico
-
Barranquilla, Atlántico, Colombia, 080020
- Har ikke rekruttert ennå
- Local Institution - 0194
-
Ta kontakt med:
- Site 0194
-
Puerto Colombia, Atlántico, Colombia, 81001
- Tilbaketrukket
- Local Institution - 0182
-
-
COR
-
Montería, COR, Colombia, 230002
- Har ikke rekruttert ennå
- Local Institution - 0181
-
Ta kontakt med:
- Site 0181
-
-
Cundinamarca
-
Bogota, Cundinamarca, Colombia, 111151
- Har ikke rekruttert ennå
- Local Institution - 0327
-
Ta kontakt med:
- Site 0327
-
-
Valle del Cauca Department
-
Cali, Valle del Cauca Department, Colombia, 760032
- Har ikke rekruttert ennå
- Local Institution - 0183
-
Ta kontakt med:
- Site 0183
-
-
-
-
-
Abu Dhabi, De forente arabiske emirater
- Tilbaketrukket
- Local Institution - 0319
-
-
Abu Dhabi Emirate
-
Abu Dhabi, Abu Dhabi Emirate, De forente arabiske emirater, 11001
- Tilbaketrukket
- Local Institution - 0323
-
Abu Dhabi, Abu Dhabi Emirate, De forente arabiske emirater, 92510
- Tilbaketrukket
- Local Institution - 0318
-
Al Ain City, Abu Dhabi Emirate, De forente arabiske emirater, 15258
- Tilbaketrukket
- Local Institution - 0322
-
-
-
-
Arkansas
-
Hot Springs, Arkansas, Forente stater, 71913
- Har ikke rekruttert ennå
- Local Institution - 0303
-
Ta kontakt med:
- Site 0303
-
-
California
-
Cerritos, California, Forente stater, 90703
- Tilbaketrukket
- Local Institution - 0307
-
Cerritos, California, Forente stater, 90703
- Tilbaketrukket
- Local Institution - 0308
-
Cerritos, California, Forente stater, 90703
- Tilbaketrukket
- Local Institution - 0309
-
Cerritos, California, Forente stater, 90703
- Aktiv, ikke rekrutterende
- Local Institution - 0328
-
Long Beach, California, Forente stater, 90805
- Tilbaketrukket
- Local Institution - 0311
-
Los Angeles, California, Forente stater, 90033
- Fullført
- Local Institution - 0290
-
Los Angeles, California, Forente stater, 90067
- Fullført
- Local Institution - 0283
-
Newport Beach, California, Forente stater, 92663
- Fullført
- Local Institution - 0353
-
Stanford, California, Forente stater, 94305
- Tilbaketrukket
- Local Institution - 0358
-
-
Colorado
-
Aurora, Colorado, Forente stater, 80045
- Har ikke rekruttert ennå
- Local Institution - 0289
-
Ta kontakt med:
- Site 0289
-
Denver, Colorado, Forente stater, 80220
- Aktiv, ikke rekrutterende
- Local Institution - 0367
-
-
Delaware
-
Newark, Delaware, Forente stater, 19713
- Fullført
- Local Institution - 0304
-
-
Florida
-
Pembroke Pines, Florida, Forente stater, 33028
- Tilbaketrukket
- Local Institution - 0296
-
-
Georgia
-
Atlanta, Georgia, Forente stater, 30322
- Fullført
- Local Institution - 0294
-
Atlanta, Georgia, Forente stater, 30342
- Fullført
- Local Institution - 0357
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60637
- Har ikke rekruttert ennå
- Local Institution - 0280
-
Ta kontakt med:
- Site 0280
-
Chicago, Illinois, Forente stater, 60612
- Tilbaketrukket
- Local Institution - 0278
-
Decatur, Illinois, Forente stater, 62526
- Fullført
- Local Institution - 0275
-
O'Fallon, Illinois, Forente stater, 62269
- Tilbaketrukket
- Local Institution - 0324
-
-
Louisiana
-
Covington, Louisiana, Forente stater, 70433
- Fullført
- Local Institution - 0286
-
-
Maryland
-
Baltimore, Maryland, Forente stater, 21201
- Tilbaketrukket
- Local Institution - 1035
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02114
- Fullført
- Local Institution - 0288
-
Boston, Massachusetts, Forente stater, 02215
- Aktiv, ikke rekrutterende
- Local Institution - 0287
-
-
Michigan
-
Detroit, Michigan, Forente stater, 48202
- Fullført
- Local Institution - 0359
-
-
Minnesota
-
Maple Grove, Minnesota, Forente stater, 55369
- Fullført
- Local Institution - 0313
-
Minneapolis, Minnesota, Forente stater, 55455
- Tilbaketrukket
- Local Institution - 0372
-
-
Missouri
-
Kansas City, Missouri, Forente stater, 64111
- Fullført
- Local Institution - 0284
-
-
New York
-
New York, New York, Forente stater, 10016
- Tilbaketrukket
- Local Institution - 0312
-
New York, New York, Forente stater, 10065
- Fullført
- Local Institution - 0279
-
Syracuse, New York, Forente stater, 13210
- Tilbaketrukket
- Local Institution - 1037
-
Westbury, New York, Forente stater, 11590
- Fullført
- Local Institution - 0295
-
White Plains, New York, Forente stater, 10601
- Fullført
- Local Institution - 0285
-
-
North Carolina
-
Durham, North Carolina, Forente stater, 27710
- Fullført
- Local Institution - 0276
-
-
Oregon
-
Eugene, Oregon, Forente stater, 97401
- Fullført
- Local Institution - 0316
-
-
Pennsylvania
-
Allentown, Pennsylvania, Forente stater, 18103
- Aktiv, ikke rekrutterende
- Local Institution - 0356
-
Philadelphia, Pennsylvania, Forente stater, 19104
- Fullført
- Local Institution - 0310
-
Pittsburgh, Pennsylvania, Forente stater, 15213-3403
- Tilbaketrukket
- Local Institution - 0360
-
-
South Carolina
-
Greenville, South Carolina, Forente stater, 29607
- Fullført
- Local Institution - 0281
-
-
Texas
-
Austin, Texas, Forente stater, 78705
- Fullført
- Local Institution - 0315
-
El Paso, Texas, Forente stater, 79902
- Fullført
- Local Institution - 0368
-
Flower Mound, Texas, Forente stater, 75028
- Aktiv, ikke rekrutterende
- Local Institution - 0305
-
Houston, Texas, Forente stater, 77024-2843
- Fullført
- Local Institution - 0314
-
-
Virginia
-
Midlothian, Virginia, Forente stater, 23114
- Aktiv, ikke rekrutterende
- Local Institution - 0277
-
Roanoke, Virginia, Forente stater, 24014
- Har ikke rekruttert ennå
- Local Institution - 0301
-
Ta kontakt med:
- Site 0301
-
Winchester, Virginia, Forente stater, 22601
- Aktiv, ikke rekrutterende
- Local Institution - 0302
-
-
-
-
-
Lille, Frankrike, 59000
- Fullført
- Local Institution - 0094
-
Paris, Frankrike, 75248
- Tilbaketrukket
- Local Institution - 0088
-
-
Aquitaine
-
Bordeaux, Aquitaine, Frankrike, 33076
- Aktiv, ikke rekrutterende
- Local Institution - 0089
-
-
Auvergne-Rhône-Alpes
-
Lyon, Auvergne-Rhône-Alpes, Frankrike, 69008
- Tilbaketrukket
- Local Institution - 0090
-
-
Côte-d'Or
-
Dijon, Côte-d'Or, Frankrike, 21079
- Fullført
- Local Institution - 0272
-
-
Haute-Garonne
-
Toulouse, Haute-Garonne, Frankrike, 31059
- Tilbaketrukket
- Local Institution - 0098
-
-
Hérault
-
Montpellier, Hérault, Frankrike, 34298
- Rekruttering
- Institut Régional du Cancer Montpellier
-
Ta kontakt med:
- Marie Alexandre, Site 0095
- Telefonnummer: 33467612393
-
-
Ille-et-Vilaine
-
Rennes, Ille-et-Vilaine, Frankrike, 35042
- Fullført
- Local Institution - 0099
-
-
Loire-Atlantique
-
Saint-Herblain, Loire-Atlantique, Frankrike, 44805
- Fullført
- Local Institution - 0092
-
-
Marne
-
Reims, Marne, Frankrike, 51726
- Tilbaketrukket
- Local Institution - 0091
-
-
Paris
-
Villejuif, Paris, Frankrike, 94800
- Aktiv, ikke rekrutterende
- Local Institution - 0097
-
-
Provence-Alpes-Côte d'Azur Region
-
Marseille, Provence-Alpes-Côte d'Azur Region, Frankrike, 13273
- Rekruttering
- Institut Paoli-Calmettes
-
Ta kontakt med:
- Alexandre Tassin de Nonneville, Site 0093
- Telefonnummer: 0033621713044
-
-
Puy-de-Dôme
-
Clermont-Ferrand, Puy-de-Dôme, Frankrike, 63011
- Rekruttering
- Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne
-
Ta kontakt med:
- Olivier Collard, Site 0096
- Telefonnummer: 33473278005
-
-
Vienne
-
Poitiers, Vienne, Frankrike, 86021
- Tilbaketrukket
- Local Institution - 1033
-
-
-
-
Attica
-
Athens, Attica, Hellas, 11528
- Tilbaketrukket
- Local Institution - 0043
-
-
Attikí
-
Athens, Attikí, Hellas, 115 22
- Aktiv, ikke rekrutterende
- Local Institution - 0042
-
Athens, Attikí, Hellas, 185 47
- Fullført
- Local Institution - 0038
-
-
Irakleío
-
Heraklion, Irakleío, Hellas, 715 00
- Fullført
- Local Institution - 0086
-
-
-
-
Maharashtra
-
Mumbai, Maharashtra, India, 400 057
- Tilbaketrukket
- Local Institution - 0337
-
Mumbai, Maharashtra, India, 400012
- Tilbaketrukket
- Local Institution - 0131
-
Nagpur, Maharashtra, India, 440001
- Tilbaketrukket
- Local Institution - 0134
-
-
National Capital Territory of Delhi
-
New Delhi, National Capital Territory of Delhi, India, 110017
- Tilbaketrukket
- Local Institution - 0352
-
New Delhi, National Capital Territory of Delhi, India, 110029
- Tilbaketrukket
- Local Institution - 0266
-
New Delhi, National Capital Territory of Delhi, India, 110085
- Tilbaketrukket
- Local Institution - 0206
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, India, 600035
- Tilbaketrukket
- Local Institution - 0125
-
-
Telangana
-
Hyderabad, Telangana, India, 500082
- Tilbaketrukket
- Local Institution - 0130
-
-
Uttar Pradesh
-
Varanasi, Uttar Pradesh, India, 221005
- Tilbaketrukket
- Local Institution - 0133
-
-
-
-
Central District
-
Petah Tikva, Central District, Israel, 4941492
- Har ikke rekruttert ennå
- Local Institution - 0186
-
Ta kontakt med:
- Site 0186
-
Ramat Gan, Central District, Israel, 5265601
- Aktiv, ikke rekrutterende
- Local Institution - 0044
-
-
Jerusalem
-
Jerusalem, Jerusalem, Israel, 9112001
- Fullført
- Local Institution - 0047
-
-
Northern District
-
Hadera, Northern District, Israel, 38100
- Aktiv, ikke rekrutterende
- Local Institution - 0048
-
Haifa, Northern District, Israel, 3109601
- Aktiv, ikke rekrutterende
- Local Institution - 0123
-
-
-
-
-
Milan, Italia, 20141
- Aktiv, ikke rekrutterende
- Local Institution - 0052
-
Naples, Italia, 80131
- Fullført
- Local Institution - 0058
-
Novara, Italia, 28100
- Fullført
- Local Institution - 0061
-
Padova, Italia, 35128
- Fullført
- Local Institution - 0056
-
Roma, Italia, 00168
- Aktiv, ikke rekrutterende
- Local Institution - 0062
-
-
Campania
-
Naples, Campania, Italia, 80131
- Aktiv, ikke rekrutterende
- Local Institution - 0051
-
-
Emilia-Romagna
-
Bologna, Emilia-Romagna, Italia, 40138
- Fullført
- Local Institution - 0049
-
-
Friuli Venezia Giulia
-
Aviano, Friuli Venezia Giulia, Italia, 33081
- Aktiv, ikke rekrutterende
- Local Institution - 0057
-
-
Liguria
-
Genoa, Liguria, Italia, 16132
- Fullført
- Local Institution - 0054
-
-
Pisa
-
Pontedera, Pisa, Italia, 56025
- Aktiv, ikke rekrutterende
- Local Institution - 0053
-
-
Tuscany
-
Prato, Tuscany, Italia, 59100
- Fullført
- Local Institution - 0055
-
-
-
-
-
Fukuoka, Japan, 811-1395
- Tilbaketrukket
- Local Institution - 0242
-
Fukushima, Japan, 960-1295
- Tilbaketrukket
- Local Institution - 0225
-
Hiroshima, Japan, 7308518
- Tilbaketrukket
- Local Institution - 0243
-
Kyoto, Japan, 606-8507
- Tilbaketrukket
- Local Institution - 0235
-
Okayama, Japan, 700-8558
- Tilbaketrukket
- Local Institution - 0241
-
Osaka, Japan, 541-8567
- Tilbaketrukket
- Local Institution - 0239
-
-
Aichi-ken
-
Nagoya, Aichi-ken, Japan, 464-8681
- Tilbaketrukket
- Local Institution - 0236
-
-
Chiba
-
Chiba, Chiba, Japan, 260-8717
- Tilbaketrukket
- Local Institution - 0230
-
-
Ehime
-
Matsuyama, Ehime, Japan, 791-0280
- Tilbaketrukket
- Local Institution - 0240
-
-
Gunma
-
Otashi, Gunma, Japan, 373-8550
- Tilbaketrukket
- Local Institution - 0226
-
-
Hokkaido
-
Sapporo, Hokkaido, Japan, 003-0804
- Tilbaketrukket
- Local Institution - 0222
-
-
Ishikawa-ken
-
Kanazawa, Ishikawa-ken, Japan, 920-8530
- Tilbaketrukket
- Local Institution - 0232
-
-
Kagoshima-ken
-
Kagoshima, Kagoshima-ken, Japan, 892-0833
- Tilbaketrukket
- Local Institution - 0244
-
-
Kanagawa
-
Isehara, Kanagawa, Japan, 259-1193
- Tilbaketrukket
- Local Institution - 0234
-
Yokohama, Kanagawa, Japan, 2418515
- Tilbaketrukket
- Local Institution - 0237
-
-
Mie-ken
-
Tsu, Mie-ken, Japan, 514-8507
- Tilbaketrukket
- Local Institution - 0246
-
-
Miyagi
-
Sendai, Miyagi, Japan, 980-8574
- Tilbaketrukket
- Local Institution - 0223
-
-
Osaka
-
Suita, Osaka, Japan, 565-0871
- Tilbaketrukket
- Local Institution - 0238
-
-
Saitama
-
Hidaka, Saitama, Japan, 350-1298
- Tilbaketrukket
- Local Institution - 0227
-
Ina-machi, Saitama, Japan, 362-0806
- Tilbaketrukket
- Local Institution - 0224
-
-
Tokyo
-
Bunkyo-ku, Tokyo, Japan, 113-8431
- Tilbaketrukket
- Local Institution - 0231
-
Chuo-ku, Tokyo, Japan, 104-0045
- Tilbaketrukket
- Local Institution - 0229
-
Koto, Tokyo, Japan, 135-8550
- Tilbaketrukket
- Local Institution - 0228
-
Shinagawa-ku, Tokyo, Japan, 142-8666
- Tilbaketrukket
- Local Institution - 0245
-
Shinjuku-ku, Tokyo, Japan, 160-0023
- Tilbaketrukket
- Local Institution - 0233
-
-
-
-
-
Guangzhou, Kina, 510060
- Rekruttering
- Sun Yat-sen University Cancer Center
-
Ta kontakt med:
- Shusen Wang, Site 1025
- Telefonnummer: 8613926168469
-
-
Anhui
-
Hefei, Anhui, Kina, 230001
- Rekruttering
- Anhui Provincial Hospital
-
Ta kontakt med:
- Nannan Lu, Site 1002
- Telefonnummer: 8618130056850
-
Hefei, Anhui, Kina, 230601
- Rekruttering
- The Second Hospital of Anhui Medical University
-
Ta kontakt med:
- Fanfan Li, Site 1003
- Telefonnummer: +8613855137365
-
-
BEI
-
Beijing, BEI, Kina, 100021
- Rekruttering
- Cancer Hospital Chinese Academy of Medical Sciences
-
Ta kontakt med:
- Binghe Xu, Site 1001
- Telefonnummer: +86 13501028690
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Kina, 100142
- Rekruttering
- Beijing Cancer Hospital
-
Ta kontakt med:
- Huiping Li, Site 1005
- Telefonnummer: 8613811012595
-
Beijing, Beijing Municipality, Kina, 100142
- Rekruttering
- China-Japan Friendship Hospital
-
Ta kontakt med:
- Donggui Wan, Site 1024
- Telefonnummer: 8619854715414
-
-
Fujian
-
Fuzhou, Fujian, Kina, 350000
- Rekruttering
- Fujian Cancer Hospital
-
Ta kontakt med:
- Fan Wu, Site 1006
- Telefonnummer: 8613859082118
-
Fyzhou, Fujian, Kina, 350001
- Rekruttering
- Fujian Medical University Union Hospital
-
Ta kontakt med:
- Fangmeng Fu, Site 1007
- Telefonnummer: 8613365917923
-
Xiamen, Fujian, Kina, 361003
- Tilbaketrukket
- Local Institution - 1016
-
-
Gansu
-
Lanzhou, Gansu, Kina, 730000
- Rekruttering
- The First Hospital of Lanzhou University
-
Ta kontakt med:
- Xiaoling Ling, Site 1031
- Telefonnummer: 8618693165668
-
-
Guangxi
-
Nanning, Guangxi, Kina, 530021
- Rekruttering
- Guangxi Medical University Affiliated Cancer Hospital
-
Ta kontakt med:
- Wei Wei, Site 1008
- Telefonnummer: 8618577071966
-
-
HUN
-
Changsha, HUN, Kina, 410013
- Har ikke rekruttert ennå
- Local Institution - 1011
-
Ta kontakt med:
- Site 1011
-
-
Harbin
-
Harbin, Harbin, Kina, 150001
- Rekruttering
- The First Hospital of harbin University
-
Ta kontakt med:
- Li Cai, Site 1028
- Telefonnummer: 8613313602929
-
-
Henan
-
Anyang, Henan, Kina, 455110
- Rekruttering
- Anyang Cancer Hospital
-
Ta kontakt med:
- Junlan Guo, Site 1004
- Telefonnummer: 8615037272967
-
Zhengzhou, Henan, Kina, 450008
- Rekruttering
- Henan Cancer Hospital
-
Ta kontakt med:
- Min Yan, Site 1009
- Telefonnummer: 8615713857388
-
Zhengzhou, Henan, Kina, 450052
- Rekruttering
- The First Affiliated Hospital of Zhengzhou University
-
Ta kontakt med:
- Wei He, Site 1032
- Telefonnummer: +8618638553286
-
-
Hubei
-
Wuhan, Hubei, Kina, 430070
- Rekruttering
- Hubei Cancer Hospital
-
Ta kontakt med:
- Xinhong Wu, Site 1010
- Telefonnummer: 8618602726300
-
Wuhan, Hubei, Kina, 430061
- Rekruttering
- Zhongnan Hospital of Wuhan University
-
Ta kontakt med:
- Haijun Yu, Site 1021
- Telefonnummer: 8613971665181
-
Xiangyang, Hubei, Kina, 441000
- Rekruttering
- Xiangyang Central Hospital
-
Ta kontakt med:
- Yuehua Wang, Site 1022
- Telefonnummer: 8613995777482
-
-
Jiangxi
-
Nanchang, Jiangxi, Kina, 330029
- Rekruttering
- Jiangxi Cancer Hospital
-
Ta kontakt med:
- Zhengkui Sun, Site 1013
- Telefonnummer: 8613907000210
-
-
Liaoning
-
Changchun, Liaoning, Kina, 130021
- Har ikke rekruttert ennå
- Local Institution - 1012
-
Ta kontakt med:
- Site 1012
-
Shenyang, Liaoning, Kina, 140001
- Rekruttering
- Liaoning Cancer Hospital
-
Ta kontakt med:
- Tao Sun, Site 1014
- Telefonnummer: 8613940404526
-
-
Shandong
-
Jinan, Shandong, Kina, 250117
- Rekruttering
- Cancer Hospital of Shandong First Medical University
-
Ta kontakt med:
- Huihui Li, Site 1017
- Telefonnummer: 8615553103209
-
Qingdao, Shandong, Kina, 266071
- Rekruttering
- The Affiliated Hospital Of Qingdao University
-
Ta kontakt med:
- Haibo Wang, Site 1015
- Telefonnummer: 8618661805787
-
-
Shanxi
-
Taiyuan, Shanxi, Kina, 650118
- Rekruttering
- Shanxi Cancer Hospital
-
Ta kontakt med:
- Guohui Han, Site 1018
- Telefonnummer: 8613454858188
-
-
Sichuan
-
Chengdu, Sichuan, Kina, 610072
- Rekruttering
- Sichuan Provincial People'S Hospital
-
Ta kontakt med:
- Jing Luo, Site 1019
- Telefonnummer: 8618981838521
-
-
Tianjin Municipality
-
Tianjin, Tianjin Municipality, Kina, 300060
- Rekruttering
- Tianjin Cancer Hospital Airport Hospital
-
Ta kontakt med:
- Chunfang Hao, Site 1027
- Telefonnummer: 8613602031629
-
Tianjin, Tianjin Municipality, Kina, 301000
- Rekruttering
- Tianjin Medical University Cancer Institute & Hospital
-
Ta kontakt med:
- Yehui Shi, Site 1020
- Telefonnummer: 8618622221183
-
-
Yunnan
-
Kunming, Yunnan, Kina, 650118
- Rekruttering
- Yunnan Cancer Hospital
-
Ta kontakt med:
- Guojun Zhang, Site 1029
- Telefonnummer: 8618850064298
-
-
Zhejiang
-
Hangzhou, Zhejiang, Kina, 310024
- Rekruttering
- The First Affiliated Hospital, Zhejiang University School of Medicine
-
Ta kontakt med:
- Peifen Fu, Site 1023
- Telefonnummer: 8613958161556
-
Hangzhou, Zhejiang, Kina, 310022
- Har ikke rekruttert ennå
- Local Institution - 1040
-
Ta kontakt med:
- Site 1040
-
-
-
-
-
Chihuahua City, Mexico, 31207
- Rekruttering
- Scientia Investigacion Clinica S.C.
-
Ta kontakt med:
- Enrique Zamudio Lozoya, Site 0174
- Telefonnummer: 6146883416
-
-
DIF
-
Mexico City, DIF, Mexico, 03100
- Rekruttering
- CENEIT Oncologicos
-
Ta kontakt med:
- Alberto Suarez Zaizar, Site 0177
- Telefonnummer: 525555342400
-
-
Estado de Baja California
-
Tijuana, Estado de Baja California, Mexico, 22010
- Har ikke rekruttert ennå
- Local Institution - 0264
-
Ta kontakt med:
- Site 0264
-
-
Jalisco
-
Guadalajara, Jalisco, Mexico, 44680
- Har ikke rekruttert ennå
- Local Institution - 0178
-
Ta kontakt med:
- Site 0178
-
-
Mexico City
-
Mexico City, Mexico City, Mexico, 14070
- Har ikke rekruttert ennå
- Local Institution - 0329
-
Ta kontakt med:
- Site 0329
-
-
Nuevo León
-
Monterrey, Nuevo León, Mexico, 64320
- Har ikke rekruttert ennå
- Local Institution - 0175
-
Ta kontakt med:
- Site 0175
-
Monterrey, Nuevo León, Mexico, 64460
- Har ikke rekruttert ennå
- Local Institution - 0176
-
Ta kontakt med:
- Site 0176
-
Monterrey, Nuevo León, Mexico, 64460
- Tilbaketrukket
- Local Institution - 0355
-
-
Oaxaca
-
Oaxaca City, Oaxaca, Mexico, 68020
- Har ikke rekruttert ennå
- Local Institution - 0173
-
Ta kontakt med:
- Site 0173
-
-
Yucatán
-
Mérida, Yucatán, Mexico, 97000
- Har ikke rekruttert ennå
- Local Institution - 0179
-
Ta kontakt med:
- Site 0179
-
-
-
-
Greater Poland Voivodeship
-
Skórzewo, Greater Poland Voivodeship, Polen, 60-185
- Aktiv, ikke rekrutterende
- Local Institution - 0189
-
-
Lublin Voivodeship
-
Biała Podlaska, Lublin Voivodeship, Polen, 21-500
- Tilbaketrukket
- Local Institution - 0074
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Polen, 02-781
- Har ikke rekruttert ennå
- Local Institution - 0072
-
Ta kontakt med:
- Site 0072
-
Warsaw, Masovian Voivodeship, Polen, 03-411
- Aktiv, ikke rekrutterende
- Local Institution - 0220
-
-
Opole Voivodeship
-
Opole, Opole Voivodeship, Polen, 45-061
- Har ikke rekruttert ennå
- Local Institution - 0076
-
Ta kontakt med:
- Site 0076
-
-
Łódź Voivodeship
-
Lodz, Łódź Voivodeship, Polen, 93-338
- Aktiv, ikke rekrutterende
- Local Institution - 0221
-
-
-
-
-
Coimbra, Portugal, 3000-075
- Rekruttering
- Instituto Portugês de Oncologia de Coimbra Francisco Gentil
-
Ta kontakt med:
- Gabriela Sousa, Site 0124
- Telefonnummer: +351239400200
-
Lisbon, Portugal, 1500-650
- Rekruttering
- Hospital da Luz Lisboa
-
Ta kontakt med:
- Catarina Pulido, Site 0141
- Telefonnummer: +351917187738
-
Porto, Portugal, 4200-072
- Rekruttering
- Instituto Português de Oncologia do Porto Francisco Gentil, EPE
-
Ta kontakt med:
- Cristina Oliveira, Site 0111
-
Porto, Portugal, 4200-319
- Rekruttering
- Centro Hospitalar de Sao Joao - Hospital de Sao Joao
-
Ta kontakt med:
- Isabel Augusto, Site 0253
- Telefonnummer: +351963903409
-
-
Lisbon District
-
Lisbon, Lisbon District, Portugal, 1649-035
- Rekruttering
- Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa Maria
-
Ta kontakt med:
- Luis Costa, Site 0109
- Telefonnummer: 351217805257
-
Lisbon, Lisbon District, Portugal, 1400-038
- Har ikke rekruttert ennå
- Local Institution - 0106
-
Ta kontakt med:
- Site 0106
-
Lisbon, Lisbon District, Portugal, 1099-023
- Rekruttering
- Instituto Português de Oncologia de Lisboa Francisco Gentil
-
Ta kontakt med:
- Patricia Pereira, Site 0198
-
-
-
-
-
Bucharest, Romania, 011171
- Aktiv, ikke rekrutterende
- Local Institution - 0083
-
Cluj-Napoca, Romania, 400015
- Aktiv, ikke rekrutterende
- Local Institution - 0077
-
Dumbrăviţa, Romania, 307160
- Fullført
- Local Institution - 0211
-
Iași, Romania, 700106
- Aktiv, ikke rekrutterende
- Local Institution - 0081
-
Iași, Romania, 700483
- Fullført
- Local Institution - 0080
-
Ploieşti, Romania, 100337
- Aktiv, ikke rekrutterende
- Local Institution - 0084
-
-
Bistrița-Năsăud County
-
Bistriţa, Bistrița-Năsăud County, Romania, 420020
- Har ikke rekruttert ennå
- Local Institution - 0212
-
Ta kontakt med:
- Site 0212
-
-
Bucharest
-
Bucharest, Bucharest, Romania, 012292
- Fullført
- Local Institution - 0213
-
-
Cluj
-
Florești, Cluj, Romania, 407280
- Aktiv, ikke rekrutterende
- Local Institution - 0079
-
-
Dolj
-
Craiova, Dolj, Romania, 200746
- Fullført
- Local Institution - 0078
-
-
Timiș County
-
Timișoara, Timiș County, Romania, 300239
- Aktiv, ikke rekrutterende
- Local Institution - 0085
-
-
-
-
-
Madrid, Spania, 28007
- Fullført
- Local Institution - 0107
-
Seville, Spania, 41009
- Rekruttering
- Hospital Universitario Virgen Macarena
-
Ta kontakt med:
- Luis de la Cruz Merino, Site 0103
- Telefonnummer: +34955926578
-
-
A Coruña [La Coruña]
-
A Coruña, A Coruña [La Coruña], Spania, 15006
- Rekruttering
- CHUAC-Hospital Teresa Herrera
-
Ta kontakt med:
- Silvia Antolin Novoa, Site 0105
- Telefonnummer: +34981178000
-
-
Alicante
-
Elche, Alicante, Spania, 03203
- Rekruttering
- Hospital General Universitario de Elche
-
Ta kontakt med:
- Álvaro Rodríguez-Lescure, Site 0100
- Telefonnummer: 111-111-1111
-
-
Barcelona [Barcelona]
-
Barcelona, Barcelona [Barcelona], Spania, 08035
- Rekruttering
- Hospital Universitari Vall d'Hebron
-
Ta kontakt med:
- Ana Mafalda Antunes de Melo e Oliveira, Site 0102
- Telefonnummer: 34934894158
-
Hospitalet, Barcelona [Barcelona], Spania, 08907
- Fullført
- Local Institution - 0172
-
-
Catalunya [Cataluña]
-
Barcelona, Catalunya [Cataluña], Spania, 08036
- Rekruttering
- Hospital Clínic de Barcelona
-
Ta kontakt med:
- Marta González Rodríguez, Site 0140
- Telefonnummer: +34606895621
-
-
Gipuzkoa
-
Donostia / San Sebastian, Gipuzkoa, Spania, 20014
- Rekruttering
- Hospital Universitario Donostia
-
Ta kontakt med:
- Isabel Alvarez Lopez, Site 0139
- Telefonnummer: 34943006002
-
-
Madrid, Comunidad de
-
Madrid, Madrid, Comunidad de, Spania, 28009
- Rekruttering
- Hospital General Universitario Gregorio Marañon
-
Ta kontakt med:
- Sara Lopez Tarruella, Site 0104
- Telefonnummer: 34914269392
-
Madrid, Madrid, Comunidad de, Spania, 28041
- Fullført
- Local Institution - 0108
-
-
Málaga
-
Málaga, Málaga, Spania, 29010
- Rekruttering
- Hospital Universitario Virgen de la Victoria
-
Ta kontakt med:
- Maria Emilia Dominguez Recio, Site 0101
- Telefonnummer: 34951291425
-
-
Valenciana, Comunitat
-
Valencia, Valenciana, Comunitat, Spania, 46010
- Rekruttering
- Hospital Clinico de Valencia
-
Ta kontakt med:
- Begona Bermejo de las Heras, Site 0210
- Telefonnummer: 34961973583
-
-
-
-
-
Belfast, Storbritannia, BT9 7AB
- Tilbaketrukket
- Local Institution - 0171
-
Manchester, Storbritannia, M20 4BX
- Aktiv, ikke rekrutterende
- Local Institution - 0001
-
Nottingham, Storbritannia, NG5 1PB
- Har ikke rekruttert ennå
- Local Institution - 0006
-
Ta kontakt med:
- Site 0006
-
-
England
-
Truro, England, Storbritannia, TR1 3LJ
- Fullført
- Local Institution - 0208
-
-
London, City of
-
London, London, City of, Storbritannia, SE1 9RT
- Tilbaketrukket
- Local Institution - 0204
-
London, London, City of, Storbritannia, EC1A 7BE
- Aktiv, ikke rekrutterende
- Local Institution - 0004
-
London, London, City of, Storbritannia, SE1 9RT
- Fullført
- Local Institution - 0209
-
-
-
-
-
Zurich, Sveits, 8008
- Aktiv, ikke rekrutterende
- Local Institution - 0251
-
-
Canton of St. Gallen
-
Sankt Gallen, Canton of St. Gallen, Sveits, 9007
- Aktiv, ikke rekrutterende
- Local Institution - 0250
-
-
Canton of Vaud
-
Lausanne, Canton of Vaud, Sveits, 1011
- Aktiv, ikke rekrutterende
- Local Institution - 0249
-
-
-
-
Skåne Län [se-12]
-
Malmö, Skåne Län [se-12], Sverige, 205 02
- Aktiv, ikke rekrutterende
- Local Institution - 0252
-
-
Stockholms Län [se-01]
-
Stockholm, Stockholms Län [se-01], Sverige, 112 19
- Aktiv, ikke rekrutterende
- Local Institution - 0026
-
-
Uppsala Län [se-03]
-
Uppsala, Uppsala Län [se-03], Sverige, 751 85
- Aktiv, ikke rekrutterende
- Local Institution - 0025
-
-
Örebro Län [se-18]
-
Örebro, Örebro Län [se-18], Sverige, 701 85
- Aktiv, ikke rekrutterende
- Local Institution - 0024
-
-
Östergötlands Län [se-05]
-
Linköping, Östergötlands Län [se-05], Sverige, 581 85
- Aktiv, ikke rekrutterende
- Local Institution - 0247
-
-
-
-
Kyǒnggi-do
-
Goyang-si, Kyǒnggi-do, Sør -Korea, 10408
- Har ikke rekruttert ennå
- Local Institution - 0066
-
Ta kontakt med:
- Site 0066
-
Seongnam, Kyǒnggi-do, Sør -Korea, 13620
- Har ikke rekruttert ennå
- Local Institution - 0067
-
Ta kontakt med:
- Site 0067
-
-
Seoul-teukbyeolsi [Seoul]
-
Seoul, Seoul-teukbyeolsi [Seoul], Sør -Korea, 02841
- Har ikke rekruttert ennå
- Local Institution - 0068
-
Ta kontakt med:
- Site 0068
-
Seoul, Seoul-teukbyeolsi [Seoul], Sør -Korea, 03080
- Har ikke rekruttert ennå
- Local Institution - 0063
-
Ta kontakt med:
- Site 0063
-
Seoul, Seoul-teukbyeolsi [Seoul], Sør -Korea, 03722
- Har ikke rekruttert ennå
- Local Institution - 0071
-
Ta kontakt med:
- Site 0071
-
Seoul, Seoul-teukbyeolsi [Seoul], Sør -Korea, 05505
- Har ikke rekruttert ennå
- Local Institution - 0064
-
Ta kontakt med:
- Site 0064
-
Seoul, Seoul-teukbyeolsi [Seoul], Sør -Korea, 06351
- Har ikke rekruttert ennå
- Local Institution - 0065
-
Ta kontakt med:
- Site 0065
-
-
Taegu-Kwangyǒkshi
-
Daegu, Taegu-Kwangyǒkshi, Sør -Korea, 41404
- Har ikke rekruttert ennå
- Local Institution - 0069
-
Ta kontakt med:
- Site 0069
-
-
-
-
-
Johannesburg, Sør-Afrika, 2193
- Tilbaketrukket
- Local Institution - 0342
-
Pretoria, Sør-Afrika, 0001
- Tilbaketrukket
- Local Institution - 0336
-
Pretoria, Sør-Afrika, 0084
- Tilbaketrukket
- Local Institution - 0341
-
Soweto, Sør-Afrika, 2013
- Tilbaketrukket
- Local Institution - 0340
-
-
Eastern Cape
-
East London, Eastern Cape, Sør-Afrika, 5241
- Har ikke rekruttert ennå
- Local Institution - 0351
-
Ta kontakt med:
- Site 0351
-
-
Western Cape
-
Cape Town, Western Cape, Sør-Afrika, 7570
- Tilbaketrukket
- Local Institution - 1034
-
-
-
-
-
Adana, Tyrkia (Türkiye), 01123
- Har ikke rekruttert ennå
- Local Institution - 0361
-
Ta kontakt med:
- Site 0361
-
Ankara, Tyrkia (Türkiye), 06800
- Har ikke rekruttert ennå
- Local Institution - 0362
-
Ta kontakt med:
- Site 0362
-
Istanbul, Tyrkia (Türkiye), 34722
- Har ikke rekruttert ennå
- Local Institution - 0363
-
Ta kontakt med:
- Site 0363
-
Istanbul, Tyrkia (Türkiye), 34010
- Har ikke rekruttert ennå
- Local Institution - 0364
-
Ta kontakt med:
- Site 0364
-
-
-
-
-
Berlin, Tyskland, 10117
- Aktiv, ikke rekrutterende
- Local Institution - 0261
-
Berlin, Tyskland, 10967
- Aktiv, ikke rekrutterende
- Local Institution - 0260
-
Bonn, Tyskland, 53111
- Aktiv, ikke rekrutterende
- Local Institution - 0259
-
Dresden, Tyskland, 01307
- Aktiv, ikke rekrutterende
- Local Institution - 0258
-
Heidelberg, Tyskland, D-69120
- Aktiv, ikke rekrutterende
- Local Institution - 0262
-
Ulm, Tyskland, 89081
- Aktiv, ikke rekrutterende
- Local Institution - 0291
-
-
Baden-Wurttemberg
-
Esslingen am Neckar, Baden-Wurttemberg, Tyskland, 73730
- Aktiv, ikke rekrutterende
- Local Institution - 0320
-
-
Bavaria
-
Augsburg, Bavaria, Tyskland, 86156
- Aktiv, ikke rekrutterende
- Local Institution - 0256
-
München, Bavaria, Tyskland, 80637
- Aktiv, ikke rekrutterende
- Local Institution - 0271
-
-
Hesse
-
Frankfurt am Main, Hesse, Tyskland, 60590
- Aktiv, ikke rekrutterende
- Local Institution - 0306
-
Langen, Hesse, Tyskland, 63225
- Aktiv, ikke rekrutterende
- Local Institution - 0333
-
-
Lower Saxony
-
Hanover, Lower Saxony, Tyskland, 30625
- Aktiv, ikke rekrutterende
- Local Institution - 0257
-
-
North Rhine-Westphalia
-
Düsseldorf, North Rhine-Westphalia, Tyskland, 40235
- Fullført
- Local Institution - 0293
-
Essen, North Rhine-Westphalia, Tyskland, 45136
- Aktiv, ikke rekrutterende
- Local Institution - 0263
-
-
Saxony
-
Leipzig, Saxony, Tyskland, 04103
- Har ikke rekruttert ennå
- Local Institution - 0254
-
Ta kontakt med:
- Site 0254
-
-
Schleswig-Holstein
-
Lübeck, Schleswig-Holstein, Tyskland, 23538
- Fullført
- Local Institution - 0255
-
-
-
-
-
Salzburg, Østerrike, 5020
- Aktiv, ikke rekrutterende
- Local Institution - 0267
-
Sankt Pölten, Østerrike, 3100
- Aktiv, ikke rekrutterende
- Local Institution - 0270
-
Vienna, Østerrike, 1090
- Aktiv, ikke rekrutterende
- Local Institution - 0269
-
-
Styria
-
Graz, Styria, Østerrike, 8036
- Aktiv, ikke rekrutterende
- Local Institution - 0292
-
-
Tyrol
-
Innsbruck, Tyrol, Østerrike, 6020
- Aktiv, ikke rekrutterende
- Local Institution - 0268
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria
-
Histologically or cytologically confirmed and documented locally-advanced, recurrent inoperable, or metastatic triple-negative breast cancer (TNBC) (ER < 1%, PgR < 1%, HER2 IHC 0, 1+, or 2+ with ISH negative for HER2 gene amplification) or ER-low, HER2-negative BC (ER and / or PgR 1% to 10%, HER2 IHC 0, 1+, or 2+ with ISH negative for HER2 gene amplification) per American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) criteria, based on the most recently analyzed biopsy or other pathology specimen.
-
Patients with recurrent disease must have experienced disease relapse at least 6 months after finishing their last therapy with curative intent.
-
Participants with TNBC must be considered ineligible for 1L chemotherapy combination treatment with an anti-PD-1 (eg, pembrolizumab) or an anti-PD-L1 (eg, atezolizumab) due to any one of the following criteria:
i) Investigator-determined ineligibility based on PD-L1 negative disease determined and documented prior to trial screening as part of standard of care (SoC); ii) Has experienced disease relapse between 6 to 12 months after the completion of (neo)adjuvant therapy with an anti-PD(L)1; iii) Has a severe auto-immune disease or other contraindication, in the opinion of the investigator, for the use of an anti-PD(L)1 drug: iv) Any auto-immune disease that requires current immunosuppression (eg, methotrexate, cyclophosphamide, prednisone > 10 mg/day).
v) Prior auto-immune AE to peri-adjuvant ICI that required immunosuppression. vi) Current Graves' disease with ophthalmopathy or in need of radioiodine or in use of antithyroid medication.
vii) Current or prior auto-immune diseases per below: A. Moderate to severe rheumatoid arthritis. B. Auto-immune hepatitis or cholangitis. C. Myasthenia gravis. D. Moderate-to-severe or poorly controlled inflammatory bowel disease. E. Multiple sclerosis. F. Lupus with kidney involvement or moderate to severe lupus. G. Auto-immune myocarditis. Note: if participant meets Inclusion Criteria 5b or 5c, unknown PDL1 results per local SOC are acceptable in these specific cases.
- Patients with ER-low, HER2-negative BC must be ineligible, in the opinion of the Investigator, for endocrine therapy-based treatments.
- No previous systemic therapy in the locally advanced, recurrent inoperable or metastatic setting (ie incurable setting).
- Measurable disease by CT or MRI as per RECIST v1.1.
Exclusion Criteria
-
Participants with a known germline breast cancer gene (BRCA) 1 or 2 mutation whose best 1L treatment option, in the opinion of the investigator, is a poli-ADP-ribose-polymerase inhibitors (PARPi).
-
Untreated symptomatic central nervous system (CNS) metastases. Participants are eligible if CNS metastases have been treated, and participants' neurological signs and symptoms have returned to baseline. In addition, participants must have been either off corticosteroids, or on a stable or decreasing dose of ≤ 10 mg daily prednisone (or equivalent) for at least 2 weeks prior to randomization. Imaging performed within 28 days of randomization must document radiographic stability of CNS lesions and be performed after completion of any CNS directed therapy.
-
Leptomeningeal metastases.
-
Participants with history of severe heart disease including, but not limited to, any of the following:
i) History of clinically significant heart disease (eg, cardiomyopathy, congestive heart failure with New York Heart Association functional classification II to IV, pericarditis, or significant pericardial effusion).
ii) Myocardial infarction, uncontrolled angina, or stroke/transient ischemic attack within the past 6 months.
iii) QTc (by Fridericia's formula) prolongation ≥ 450 msec for males and ≥ 470 msec for females, except for right bundle branch block.
iv) Known LVEF < 50%.
- Prior therapy with iza-bren or any other ADC targeting EGFR and/or HER3 or containing a topoisomerase 1 inhibitor payload.
- Other protocol-defined Inclusion/Exclusion criteria apply.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Aktiv komparator: Arm B
|
Specified dose on specified days Specified dose on specified days Specified dose on specified days Specified dose on specified days Specified dose on specified days |
|
Eksperimentell: Arm A1
|
Specified dose on specified days
Andre navn:
|
|
Eksperimentell: Arm A2
|
Specified dose on specified days
Andre navn:
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Recommended Phase 3 Dose (RP3D) of BMS-986507
Tidsramme: Approximately 13 months from first participant randomization in Phase 2
|
Approximately 13 months from first participant randomization in Phase 2
|
|
|
Progression-Free Survival (PFS)
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by blinded independent central review (BICR) |
Approximately 22 months from first participant randomization in Phase 3
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Overall Survival (OS)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with treatment-related Adverse Events (AEs)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with laboratory abnormalities
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with serious AEs (SAEs)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of participants with AEs leading to treatment discontinuation, interruption, dose reduction or dose delay
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Number of deaths
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Objective Response (OR) per BICR
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Objective Response (OR) per Investigator
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Relative change in tumor size
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Disease control rate (DCR) per BICR
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Disease control rate (DCR) per Investigator
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Duration of Response (DOR) per BICR
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Duration of response (DOR) per Investigator
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Time to Response (TTR) per BICR
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Time to response (TTR) per Investigator
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Approximately 22 months from first participant randomization in Phase 3
|
|
|
Change from baseline in European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Change from baseline in EORTC Breast Cancer-specific Quality of Life Questionnaire (QLQ-BR23)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Functional Assessment of Chronic Illness Therapy item GP5 (FACIT GP5) score
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
Change from baseline in European Quality of Life 5 Dimensions 5 Levels (EQ-5D-5L)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Approximately up to 47 months from first participant randomization in Phase 3
|
|
|
PFS rate
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by BICR |
Approximately 22 months from first participant randomization in Phase 3
|
|
PFS rate
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1) by Investigator |
Approximately 22 months from first participant randomization in Phase 3
|
|
PFS
Tidsramme: Approximately 22 months from first participant randomization in Phase 3
|
Assessed by Investigator |
Approximately 22 months from first participant randomization in Phase 3
|
|
Time to subsequent treatment (TTST) per Investigator
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Defined as time from randomization to the start of subsequent therapy or death |
Approximately up to 47 months from first participant randomization in Phase 3
|
|
Progression-free survival after next line of treatment (PFS2)
Tidsramme: Approximately up to 47 months from first participant randomization in Phase 3
|
Defined as the time from randomization to the date of investigator-defined documented disease progression after next line of treatment or death due to any cause, whichever comes first |
Approximately up to 47 months from first participant randomization in Phase 3
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Samarbeidspartnere
Samarbeidspartnere
Etterforskere
Etterforskere
- Studieleder: Bristol-Myers Squibb, Bristol-Myers Squibb
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Neoplasmer etter nettsted
- Neoplasmer
- Hudsykdommer
- Bryst sykdommer
- Hud- og bindevevssykdommer
- Brystneoplasmer
- Trippel negative brystneoplasmer
- Organiske kjemikalier
- Heterocykliske forbindelser, 1-ring
- Heterocykliske forbindelser
- Nukleinsyrer, nukleotider og nukleosider
- Hydrokarboner
- Cycloparaffins
- Hydrokarboner, alicyklisk
- Hydrokarboner, syklisk
- Terpener
- Koordinasjonskomplekser
- Taxoider
- Cyclodecanes
- Diterpenes
- Deoxycytidine
- Cytidin
- Pyrimidin -nukleosider
- Pyrimidiner
- Nukleosider
- Uracil
- Pyrimidinoner
- Deoxyribonucleosides
- Fluorouracil
- Capecitabin
- Gemcitabin
- Karboplatin
- Paclitaxel
- 130-nm albuminbundet paclitaxel
Andre studie-ID-numre
Andre studie-ID-numre
- CA244-0008
- 2024-519871-24 (Annen identifikator: EU CTR)
- U1111-1316-1533 (Annen identifikator: WHO)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
IPD-delingstidsramme
See Plan Description
Tilgangskriterier for IPD-deling
See Plan Description
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- CSR
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .